Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies. Formerly @twoXAR
Palo Alto, CA
Joined December 2015
- Tweets401
- Following87
- Followers1.1K
- Likes281
Aria VP of Discovery @AaronCDaugherty shares his opinion on what to expect in #AI in #drugdiscovery in 2023 in the latest edition of @DrugTargetRev
In this exclusive article, @AaronCDaugherty from @ariapharma highlights how the industry can use AI to transform research.
Read more here: drugtargetreview.com/article…
#bioinformatics #artificialintelligence #drugdiscovery #AI
ALT Global network. Blockchain. 3D illustration. Neural networks and artificial intelligence. Abstract technological background with binary code elements
"The next wave of innovation in AI must examine how all the puzzle pieces of human biology are connected..." Aria SVP of R&D Mark G. Eller discussing technology as a new evolution of finding disease. ariapharmaceuticals.com/tech…
"That early exploration is the phase where disruptive technology can have a significant impact and bring more potential treatments to the clinic." Read more from Aria SVP of R&D Mark G. Eller discussing technology as the new evolution in fighting diseases.
pharmtech.com/view/technolog…
"In 2022, Aria Pharmaceuticals made significant headway on nearly every front in our mission to bring novel and needed treatments into the clinic." Read more from CEO @andrew_radin as he reflects on Aria's progress in 2022.
ariapharma.medium.com/more-p…
2022 was a year of progress for Aria. CEO @andrew_radin shared his thoughts on this year's accomplishments and looks ahead at 2023 and what's to come. ariapharma.medium.com/more-p…
We were pleased to have SVP of Nonclinical R&D and Chemistry Anjali Pandey present at the 6th Obesity & NASH Drug Development Summit where she presented on our latest data in #NASH. If you missed the presentation, you can now view it here: ariapharmaceuticals.com/scie…
"I believe it is safe to say that with these traditional lab-based approaches, we have missed potential breakthroughs." Read more from VP Discovery @AaronCDaugherty on how a new approach could help us uncover new promising treatments in @DrugTargetRev
ariapharmaceuticals.com/how-…
Using our Symphony™ AI-platform, @ariapharma has developed a robust pipeline of promising treatments across a range of complex diseases. Learn more about how Symphony™ is purpose-built for biological discovery: ariapharmaceuticals.com/symp…
Aria Pharmaceuticals retweeted
Promising results from the third preclinical study of TRX-1002, an #IdiopathicPulmonaryFibrosis (#IPF) treatment candidate, showed significant decrease in #AbsoluteLungWeight, #FibrosisScore, and collagen and hydroxyproline levels @ariapharma fal.cn/3u61e #CureIPF
Thanks to Pulmonary Fibrosis News for covering our latest findings in our IPF program! Here's a nice roundup of the data Anjali Pandey presented at the Antifibrotic Drug Development Summit in Boston.
pulmonaryfibrosisnews.com/ne…
The 6th Obesity & NASH Drug Development Summit kicks off tomorrow! Don't miss Aria SVP of Nonclinical R&D and Chemistry Anjali Pandey presenting on our latest findings in #NASH.
ALT Infocard for Obesity and NASH Summit with photo of speaker Anjali Pandey and title of talk.
Don't miss Aria SVP of Nonclinical R&D and Chemistry Anjali Pandey at the 6th Obesity and NASH Drug Development Summit next week where she'll be sharing the latest data from our #NASH program!
obesity-and-nash-summit.com/
We're please to announce the latest positive results from our IPF program presented at the AFDD Summit! This demonstrates another positive result for our lead TXR-1002 as we move closer to the clinic with a potential treatment for #IPF
prnewswire.com/news-releases…
Following a recent @statnews article from @matthewherper discussing why we're not prepared for the next wave of innovation, our VP Discovery @AaronCDaugherty shared his thoughts on how a shift in mindset can facilitate better results in drug discovery: ariapharma.medium.com/we-mus…
This is biology's century - "Here’s what “biology’s century” means to me: In the same way the 20th century belonged to physics, the 21st is biological." A great piece from @matthewherper
statnews.com/2022/11/03/why-…
It was an honor to have CEO @andrew_radin share the latest from Aria with the @mit_ilp in Seoul at the Startup Showcase and meet with other industry members!
ALT Photo of Aria CEO Andrew Radin presenting slides at the MIT Startup Showcase in Seoul
Join Aria SVP of Nonclinical R&D & Chemistry Anjali Pandey at the AFDD Summit Nov 9-11 where she'll be sharing the latest data from our #IPF program along with updates in #NASH. afdd-summit.com/
ALT Speaker profile for Anjali Pandey at the AFDD Summit with presentation title: Pipeline Peak 2: Leveraging AI from Human Derived Data to Identify Leads and Establish Efficacy for IPF & NASH
October is #healthylungmonth! Now is the perfect time to check on your lung health and follow these tips to help prevent lung-related illnesses!
ALT Healthy lung month infographic with tips on preventing lung related illnesses, including: quit smoking and vaping, check air quality, mask to minimize exposure to pollutants and viruses, eat antioxidant rich foods, exercise regularly, and get lung related vaccinations
Utilizing Symphony™ @ariapharma has developed a pipeline of promising treatments in over a dozen programs across a range of therapeutic areas. Learn more about our pipeline here: ariapharmaceuticals.com/scie…